Skip to main content
. 2021 Jun 8;37(5):434–442. doi: 10.1159/000516424

Table 1.

Clinical characteristics compared by TG13 severity grading

All (n = 262) Grade 1:
mild (n = 95)
Grade 2:
moderate (n = 94)
Grade 3: Severe (n = 73) p value
Age, years 75.9 (64.8–82.8) 68.9 (61.4–78.3) 78.1 (70.4–83.3) 80.1 (66.3–83.8) <0.001
Male gender 129 (49.2) 43 (45.3) 45 (47.9) 41 (56.2) 0.355
Diabetes mellitus 100 (38.2) 32 (33.7) 33 (35.1) 35 (47.9) 0.126
Ischemic heart disease 53 (20.2) 16 (16.8) 15 (16.0) 22 (30.1) 0.046
COPD/asthma 12 (4.6) 4 (4.2) 6 (6.4) 2 (2.7) 0.523
Chronic renal impairment 38 (14.5) 12 (12.6) 12 (12.8) 14 (19.2) 0.41
History of biliary disease 136 (51.9) 46 (48.4) 52 (55.3) 38 (52.1) 0.637
Abdominal pain 178 (67.9) 67 (70.5) 63 (67.0) 48 (65.8) 0.783
Pyrexia 156 (59.5) 50 (52.6) 60 (63.8) 46 (63.0) 0.227
Vomiting 123 (46.9) 45 (47.4) 42 (44.7) 36 (49.3) 0.833
Jaundice 67 (25.6) 25 (26.3) 21 (22.3) 21 (28.8) 0.627
Abdominal tenderness 136 (51.9) 51 (53.7) 45 (47.9) 40 (54.8) 0.614
Temperature, °C 37.94±1.10 37.68±0.98 38.10±1.10 38.07±1.18 0.014
Heart rate, bpm 91.77±19.09 85.64±17.06 91.56±15.27 100.01±22.84 <0.001
Systolic blood pressure, mm Hg 123.22±25.97 127.84±22.09 125.56±22.46 114.19±32.23 0.004
Respiratory rate, rpm 17.41±1.21 17.49±0.89 17.26±0.85 17.50±1.81 0.191
White blood cell count, n × 109/L 12.79±5.87 10.92±4.77 14.27±4.91 13.32±7.48 <0.001
Platelet count, n × 109/L 227.22±106.14 227.45±83.73 251.17±102.04 196.07±128.44 0.001
AST, U/L 253.11±287.26 275.45±277.24 251.01±345.95 227.07±206.78 0.255
ALT, U/L 195.84±171.72 219.22±165.04 196.98±201.92 163.96±130.08 0.09
Bilirubin, μmol/L 73.31±64.63 57.32±44.62 75.74±63.99 91±81.18 0.004
ALP, U/L 294.13±253.42 263.77±225.11 290.20±244.34 338.68±293.74 0.262
GGT, U/L 387.82±314.83 431.61±339.45 361.48±332.82 365.34±249.20 0.296
Creatinine, μmol/L 120.57±103.54 90.04±28.69 95.65±30.68 192.40±171.18 <0.001
Albumin, g/L 31.79±6.24 34.65±4.79 30.71±6.15 29.44±6.67 <0.001
Total positive blood cultures, n 95 28 31 36 0.001
Monomicrobial 79 (83.2) 27 (96.4) 28 (90.3) 24 (66.7)
Polymicrobial 16 (16.8) 1 (3.6) 3 (9.7) 12 (33.3)
E. coli 66 (69.5) 17 (60.7) 22 (71.0) 27 (75.0) 0.016
Cholelithiasis 186 (71.0) 79 (83.2) 64 (68.1) 43 (58.9) 0.002
Malignancy 45 (17.2) 9 (9.5) 17 (18.1) 19 (26.0) 0.018
Ultrasound 71 (27.1) 26 (27.4) 25 (26.6) 20 (27.4) 0.991
CT scan 104 (39.7) 34 (35.8) 42 (44.7) 28 (38.4) 0.441
MRCP scan 116 (44.3) 48 (50.5) 44 (46.8) 24 (32.9) 0.061
ERCP 146 (55.7) 63 (66.3) 50 (53.2) 33 (45.2) 0.020
Index admission cholecystectomy 14 (5.4)a 10 (10.6)a 3 (3.2) 1 (1.4) 0.039
30-day mortality 3 (1.1) 0 (0.0) 0 (0.0) 3 (4.1) 0.020
90-day mortality 11 (4.2) 2 (2.1) 3 (3.2) 6 (8.2) 0.122
In-hospital mortality 15 (5.7) 1 (1.1) 5 (5.3) 9 (12.3) 0.008

Values are presented as medians (IQR), numbers (%), or means (±SD), or numbers. COPD, chronic obstructive pulmonary disease; AST, aspartate aminotransferase; ALT, alanine transaminase; ALP, alkaline phosphatase; GGT, γ-glutamyl transferase, MRCP, magnetic resonance cholangiopancreatography. a There was a case of postcholecystectomy pancreatitis that was removed from the count.